Clinic
Silverton Health
Silverton Health was paid $29.18M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
33Billing provider infoSILVERTON HEALTH
SILVERTON, OR 97381
SILVERTON, OR 97381
33aNPI1669424354assigned 05/17/2006
33bProvider typeClinic/Center
28Total paid$29.18M
24GClaims269,036
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Oregon
Rank by total paid#2 of 167
Median peer was paid$141K
This provider vs. median207×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,477 | $1.85M | |
| 2019 | 33,179 | $2.07M | |
| 2020 | 25,554 | $3.14M | |
| 2021 | 33,273 | $3.84M | |
| 2022 | 51,010 | $5.64M | |
| 2023 | 50,280 | $6.49M | |
| 2024incomplete | 46,263 | $6.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 43,058 | 40,489 | $8.06M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 18,840 | 16,502 | $6.85M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 28,855 | 26,094 | $6.76M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.3% | 1,186 | 1,127 | $953K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 7,498 | 7,147 | $831K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 27,444 | 25,381 | $791K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 3,016 | 2,829 | $632K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 8,558 | 7,858 | $516K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 11,801 | 10,920 | $500K |
| 80053 | Comprehensive metabolic panel | 1.4% | 20,109 | 18,607 | $410K |
| 84703 | 1.1% | 8,554 | 8,141 | $329K | |
| 83690 | <1% | 7,946 | 7,392 | $281K |
86 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 3,615 | $253K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,926 | $207K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,036 | $183K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,007 | $165K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,979 | $154K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,707 | $131K |
| 81001 | <1% | 10,823 | $115K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 101 | $102K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,249 | $91K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 794 | $58K |
| 81003 | <1% | 7,225 | $56K | |
| 84484 | <1% | 2,076 | $52K | |
| 87631 | <1% | 1,180 | $48K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 329 | $47K |
| 87081 | <1% | 1,158 | $44K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,669 | $44K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 38 | $43K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 102 | $42K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,856 | $38K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,762 | $37K |
| 83735 | <1% | 2,480 | $36K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 153 | $33K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,833 | $19K |
| 82947 | <1% | 1,832 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 608 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 515 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,071 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 459 | $14K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 140 | $13K |
| 81025 | <1% | 305 | $13K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 204 | $13K |
| 74018 | <1% | 188 | $12K | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 544 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 98 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 80 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 55 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 71 | $8K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 51 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 96 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 54 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 649 | $6K |
| 83880 | <1% | 90 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,185 | $5K |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 79 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 30 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 168 | $4K |
| 93976 | <1% | 13 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 84 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 79 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 76 | $3K |
| 85379 | <1% | 88 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 88 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 76 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 316 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 67 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 32 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 42 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 183 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 62 | $1K |
| 87430 | <1% | 61 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 93 | $1K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 188 | $1K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 74 | $966.40 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 80 | $897.02 |
| 90686 | <1% | 64 | $780.00 | |
| 36592 | <1% | 44 | $678.88 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $665.42 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $644.07 |
| 99442 | <1% | 19 | $606.48 | |
| 99441 | <1% | 49 | $573.30 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 16 | $490.67 |
| 86140 | <1% | 12 | $412.67 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 125 | $394.89 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 70 | $386.43 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 17 | $302.15 |
| 83605 | <1% | 43 | $290.56 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 27 | $164.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 44 | $113.52 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 152 | $98.85 |
| 96160 | <1% | 13 | $48.63 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $42.12 |
| 82150 | <1% | 14 | $5.60 | |
| 94799 | 0% | 14 | $0.00 | |
| 82553 | 0% | 12 | $0.00 | |
| 82550 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJENSEN, SARAH (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.